Sentry Investment Management LLC lessened its holdings in shares of Zoetis Inc (NYSE:ZTS) by 50.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 38,662 shares of the company’s stock after selling 38,662 shares during the period. Sentry Investment Management LLC’s holdings in Zoetis were worth $2,785,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ZTS. Bessemer Group Inc. raised its position in shares of Zoetis by 231,590.8% during the 4th quarter. Bessemer Group Inc. now owns 2,117,654 shares of the company’s stock worth $152,557,000 after acquiring an additional 2,116,740 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Zoetis by 111.3% during the 4th quarter. Acadian Asset Management LLC now owns 1,709,352 shares of the company’s stock worth $123,143,000 after acquiring an additional 900,261 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Zoetis by 292.2% during the 4th quarter. Victory Capital Management Inc. now owns 1,063,051 shares of the company’s stock worth $76,583,000 after acquiring an additional 792,000 shares in the last quarter. Milestone Resources Group Ltd acquired a new stake in shares of Zoetis during the 4th quarter worth about $40,294,000. Finally, Public Employees Retirement Association of Colorado raised its position in shares of Zoetis by 41.6% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 1,207,018 shares of the company’s stock worth $86,954,000 after acquiring an additional 354,786 shares in the last quarter. 93.72% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have commented on the company. BMO Capital Markets set a $78.00 price target on Zoetis and gave the stock a “hold” rating in a research report on Monday, January 22nd. Piper Jaffray Companies reaffirmed a “buy” rating and set a $86.00 price target on shares of Zoetis in a research report on Thursday, January 18th. Jefferies Group reaffirmed a “buy” rating and set a $89.00 price target on shares of Zoetis in a research report on Tuesday, January 16th. Zacks Investment Research lowered Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price target on the stock. in a research report on Saturday, January 13th. Finally, Cantor Fitzgerald set a $85.00 price target on Zoetis and gave the stock a “buy” rating in a research report on Thursday, January 11th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the company. Zoetis currently has a consensus rating of “Buy” and an average target price of $73.72.

Zoetis Inc (ZTS) opened at $73.19 on Tuesday. Zoetis Inc has a 12 month low of $52.00 and a 12 month high of $80.13. The firm has a market capitalization of $35,255.31, a P/E ratio of 33.19, a price-to-earnings-growth ratio of 1.60 and a beta of 1.06. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45.

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be paid a $0.126 dividend. This is an increase from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is 26.32%.

TRADEMARK VIOLATION NOTICE: “Zoetis Inc (ZTS) Shares Sold by Sentry Investment Management LLC” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2018/02/13/zoetis-inc-zts-shares-sold-by-sentry-investment-management-llc.html.

Zoetis Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.